Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Iñigo Landa, Tihana Ibrahimpašić, Laura Boucai, et al.
Journal of Clinical Investigation (2016) Vol. 126, Iss. 3, pp. 1052-1066
Open Access | Times Cited: 1066

Showing 1-25 of 1066 citing articles:

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Sébastiano Filetti, Cosimo Durante, Dana M. Hartl, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1856-1883
Open Access | Times Cited: 889
Biologic and Clinical Perspectives on Thyroid Cancer
James A. Fagin, Samuel A. Wells
New England Journal of Medicine (2016) Vol. 375, Iss. 11, pp. 1054-1067
Open Access | Times Cited: 824
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer
Vivek Subbiah, Robert J. Kreitman, Zev A. Wainberg, et al.
Journal of Clinical Oncology (2017) Vol. 36, Iss. 1, pp. 7-13
Open Access | Times Cited: 757
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Antonino Glaviano, Aaron Song Chuan Foo, Hiu Yan Lam, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 750
Overview of the 2022 WHO Classification of Thyroid Neoplasms
Zubair Baloch, L. Sylvia, Justine A. Barletta, et al.
Endocrine Pathology (2022) Vol. 33, Iss. 1, pp. 27-63
Closed Access | Times Cited: 722
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
Lori J. Wirth, Eric J. Sherman, Bruce Robinson, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 9, pp. 825-835
Open Access | Times Cited: 605
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
Keith C. Bible, Electron Kebebew, James D. Brierley, et al.
Thyroid (2021) Vol. 31, Iss. 3, pp. 337-386
Open Access | Times Cited: 481
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
Ningni Jiang, Qijie Dai, Xiaorui Su, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 6, pp. 4587-4629
Open Access | Times Cited: 471
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
Nikita Pozdeyev, Laurie M. Gay, Ethan Sokol, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 13, pp. 3059-3068
Open Access | Times Cited: 446
The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults
Kepal N. Patel, Linwah Yip, Carrie C. Lubitz, et al.
Annals of Surgery (2020) Vol. 271, Iss. 3, pp. e21-e93
Closed Access | Times Cited: 417
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
Eleonora Molinaro, Cristina Romei, Agnese Biagini, et al.
Nature Reviews Endocrinology (2017) Vol. 13, Iss. 11, pp. 644-660
Closed Access | Times Cited: 399
Update on Fundamental Mechanisms of Thyroid Cancer
Alessandro Prete, Patricia Borges de Souza, Simona Censi, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 365
Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules
Marina N. Nikiforova, Stephanie Mercurio, Abigail I. Wald, et al.
Cancer (2018) Vol. 124, Iss. 8, pp. 1682-1690
Open Access | Times Cited: 324
Thyroid cancer
Debbie Chen, Brian Hung‐Hin Lang, Donald S.A. McLeod, et al.
The Lancet (2023) Vol. 401, Iss. 10387, pp. 1531-1544
Closed Access | Times Cited: 269
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond
Maria E. Cabanillas, Mabel Ryder, Camilo Jiménez
Endocrine Reviews (2019) Vol. 40, Iss. 6, pp. 1573-1604
Open Access | Times Cited: 268
PD-1 Blockade in Anaplastic Thyroid Carcinoma
Jaume Capdevila, Lori J. Wirth, Thomas Ernst, et al.
Journal of Clinical Oncology (2020) Vol. 38, Iss. 23, pp. 2620-2627
Open Access | Times Cited: 261
Clinical Development of BRAF plus MEK Inhibitor Combinations
Vivek Subbiah, Christina Baik, John M. Kirkwood
Trends in cancer (2020) Vol. 6, Iss. 9, pp. 797-810
Open Access | Times Cited: 258
Current practice in patients with differentiated thyroid cancer
Martin Schlumberger, Sophie Leboulleux
Nature Reviews Endocrinology (2020) Vol. 17, Iss. 3, pp. 176-188
Closed Access | Times Cited: 253
2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer
Laura Fugazzola, Rossella Elisei, Dagmar Führer, et al.
European Thyroid Journal (2019) Vol. 8, Iss. 5, pp. 227-245
Open Access | Times Cited: 240
RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies
Benjamin Solomon, Lavinia Tan, W. Marston Linehan, et al.
Journal of Thoracic Oncology (2020) Vol. 15, Iss. 4, pp. 541-549
Open Access | Times Cited: 234
Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes
Ian Ganly, Vladimir Makarov, Shyamprasad Vasudeva Deraje, et al.
Cancer Cell (2018) Vol. 34, Iss. 2, pp. 256-270.e5
Open Access | Times Cited: 229
Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis
Verena Körber, Jing Yang, Pankaj Barah, et al.
Cancer Cell (2019) Vol. 35, Iss. 4, pp. 692-704.e12
Open Access | Times Cited: 219
Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer
Seong‐Keun Yoo, Young Shin Song, Eun Kyung Lee, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 216
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma
Raj K. Gopal, Kirsten Kübler, Sarah E. Calvo, et al.
Cancer Cell (2018) Vol. 34, Iss. 2, pp. 242-255.e5
Open Access | Times Cited: 213
Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases
Bin Xu, Talia L. Fuchs, Snjezana Doğan, et al.
Thyroid (2020) Vol. 30, Iss. 10, pp. 1505-1517
Open Access | Times Cited: 210
Page 1 - Next Page

Scroll to top